A Phase Ⅰ Clinical Study of GEN-725 Tablets in Patients With Advanced Solid Tumors

NCT07229898 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: GEN-725 tablets

Sponsor

Henan Genuine Biotech Co., Ltd.